WO2023274330A1 - Method for isothermal amplification of nucleic acid target sequences - Google Patents
Method for isothermal amplification of nucleic acid target sequences Download PDFInfo
- Publication number
- WO2023274330A1 WO2023274330A1 PCT/CN2022/102545 CN2022102545W WO2023274330A1 WO 2023274330 A1 WO2023274330 A1 WO 2023274330A1 CN 2022102545 W CN2022102545 W CN 2022102545W WO 2023274330 A1 WO2023274330 A1 WO 2023274330A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stranded
- amplification
- primer
- target sequence
- dna polymerase
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 44
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 43
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 43
- 238000011901 isothermal amplification Methods 0.000 title abstract description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 103
- 230000003321 amplification Effects 0.000 claims abstract description 102
- 239000000523 sample Substances 0.000 claims abstract description 79
- 238000006243 chemical reaction Methods 0.000 claims abstract description 67
- 238000006073 displacement reaction Methods 0.000 claims abstract description 42
- 102000004190 Enzymes Human genes 0.000 claims abstract description 40
- 108090000790 Enzymes Proteins 0.000 claims abstract description 40
- 108020004414 DNA Proteins 0.000 claims abstract description 39
- 102000053602 DNA Human genes 0.000 claims abstract description 34
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims abstract description 21
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims abstract description 21
- 230000027455 binding Effects 0.000 claims abstract description 17
- 108020004682 Single-Stranded DNA Proteins 0.000 claims abstract description 16
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 58
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 58
- 230000000295 complement effect Effects 0.000 claims description 25
- 230000009471 action Effects 0.000 claims description 21
- 102100034343 Integrase Human genes 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 14
- 230000035484 reaction time Effects 0.000 claims description 14
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 11
- 239000000654 additive Substances 0.000 claims description 10
- 238000003776 cleavage reaction Methods 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 10
- 238000012986 modification Methods 0.000 claims description 10
- 230000007017 scission Effects 0.000 claims description 10
- 238000010839 reverse transcription Methods 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- 101710203526 Integrase Proteins 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- -1 Triton-x100 Chemical compound 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 230000011987 methylation Effects 0.000 claims description 3
- 238000007069 methylation reaction Methods 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 238000002715 modification method Methods 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- 230000005758 transcription activity Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 44
- 230000008569 process Effects 0.000 abstract description 8
- 239000012634 fragment Substances 0.000 abstract description 4
- 238000012123 point-of-care testing Methods 0.000 abstract 1
- 239000013615 primer Substances 0.000 description 128
- 239000000047 product Substances 0.000 description 51
- 238000010586 diagram Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000003623 enhancer Substances 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 230000000241 respiratory effect Effects 0.000 description 6
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 5
- 241000713196 Influenza B virus Species 0.000 description 4
- 238000007397 LAMP assay Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 241001647372 Chlamydia pneumoniae Species 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 241000709661 Enterovirus Species 0.000 description 3
- 101000611053 Homo sapiens Proteasome subunit beta type-2 Proteins 0.000 description 3
- 241000702617 Human parvovirus B19 Species 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 3
- 241000125945 Protoparvovirus Species 0.000 description 3
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 241000725643 Respiratory syncytial virus Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002987 primer (paints) Substances 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 208000034809 Product contamination Diseases 0.000 description 2
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002848 electrochemical method Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 241000701931 Canine parvovirus Species 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000013616 RNA primer Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000001028 reflection method Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 108700014590 single-stranded DNA binding proteins Proteins 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention belongs to the technical field of nucleic acid detection, in particular to a method for isothermally amplifying a nucleic acid target sequence.
- Polymerase chain reaction (Polymerase chain reaction, PCR) is currently the most widely used nucleic acid amplification detection technology (Nucleic Acid Amplification Test, NAAT).
- NAAT Nucleic Acid Amplification Test
- the classic reaction of this technology includes three steps of denaturation, renaturation, and extension. It is a process that requires rapid temperature cycling. It requires a specific thermal cycler for high-precision temperature control and consumes a lot of power. At the same time, the reaction time is long, which cannot meet the requirements of point-of-care detection (POCT).
- POCT point-of-care detection
- RPA recombinase polymerase amplification
- LAMP loop-mediated isothermal amplification
- SDA strand displacement amplification
- NEAR nick and extension amplification
- TMA transcription amplification. mediation technology
- RPA technology relies on three enzymes: recombinases that bind single-stranded nucleic acids, single-stranded DNA-binding proteins, and strand-displacing DNA polymerases.
- the complementary sequence of single-stranded nucleic acid is recognized by recombinase, and they are combined, and the binding region is stabilized by single-strand binding protein, and the strand displaces DNA polymerase for extension.
- the reaction is generally carried out at 37-42°C for 15-30 minutes, and special probes can be added to judge the result.
- RPA involves many components, and the cost of reagents is too high.
- LAMP uses strand displacement enzymes to complete the reaction.
- SDA uses specially modified nucleotides, endonucleases, and strand-displacing DNA polymerases, and requires 4 primers.
- the reaction time is generally 30-60min.
- NEAR is similar to SDA in that it uses nickase and strand displacement and requires only 2 primers.
- the distance between the two primers (3' ends) is 1-5 bases, through the effect of primer invasion, a product with nickase sites at both ends is formed, and the product is in the nickase and strand displacement DNA polymerase Under the effect of exponential amplification. Products can be analyzed by probes and dyes. Many products of this technology have been launched on the market. In the detection of new coronavirus nucleic acid, there have been reports of low sensitivity. Because the distance between the primers is too short, when the probe is used for real-time detection, false positives are prone to occur due to the homologous position between the primer and the probe. The reaction time is about 12 minutes.
- TMA Transcription amplification-mediated technology
- CN104726549A discloses a new method for detection of double-strand isothermal amplification based on nickase.
- the method uses three primers, one of which can be designed as a beacon probe, and the product is obtained by dye method, fluorescence method, electrochemical method, etc. method, colorimetric method, and chemical reflection method for analysis, and the detection time is 30-60min.
- Using methods other than the fluorescent method can easily lead to false positives, and the patent labels the primers so that the reaction cannot be carried out correctly. At the same time, the non-specific reaction of the labeled primers will bring false positive results. Due to factors such as too long reaction time and unreasonable product analysis, there is currently no product on the market.
- the purpose of the invention is to solve the existing technical problems of long detection time and poor specificity.
- the present invention provides a method for isothermally amplifying a nucleic acid target sequence, comprising the steps of:
- initial product formation comprises the following steps:
- the amplification primer P1 and the displacement primer are complementary combined with the single-stranded target, and the amplification primer P1 is extended along the single-stranded target under the action of DNA polymerase replacing the amplification product of the amplification primer P1 with the replacement primer; using the product formed by the extension of the replaced amplification primer P1 as a single-stranded template;
- the single-stranded template can be obtained by reacting in two ways:
- the amplification primer P1, displacement primer and DNA polymerase are contacted with single-stranded RNA, and the single-stranded RNA is Reverse transcribe into cDNA under the action of enzymatic reverse transcription activity, and be replaced by a displacement primer to obtain a single-stranded template;
- the DNA polymerase does not have the reverse transcription function, it is necessary to add a reverse transcriptase with RNase H activity, and contact the amplification primer P1 and the reverse transcriptase with the single-stranded RNA, and the single-stranded RNA Under the action of reverse transcriptase, it is reverse-transcribed into cDNA to form a cDNA-RNA composite double-stranded product, and the RNA strand in the composite double-stranded product is hydrolyzed by the RNase H activity of reverse transcriptase to obtain a single-stranded template.
- the amplification primer P2 is complementary to the single-stranded template formed in step A, and the amplification primer P2 is extended along the single-stranded template under the action of DNA polymerase, and then the nicking enzyme acts on the extension product to extend at the nick and replacement to form a double-stranded initial product with one enzyme cleavage site at each end;
- the exponential amplification signal collection comprises the following steps:
- step D Complementary binding of amplification primer P1 or P2 to the single strand formed in step C, and extension under the action of DNA polymerase to form two double strand products each with one restriction site;
- step E Contacting the nicking enzyme and the DNA polymerase with the two double-stranded products produced in step D, the two double-stranded products form nicks respectively under the action of the nicking enzyme, and the DNA polymerase amplifies from the nicking site and Replacement to obtain two single strands that can be complementary to the amplification primer P1 or P2 respectively; the single strand is then contacted with the amplification primer P1 or P2, and extended under the action of DNA polymerase to form a double-stranded product;
- step E Repeat step E to obtain the amplification product exponentially;
- Steps C to F also include complementary binding of the amplification system to molecular beacon probes to provide fluorescent signals;
- the displacement primer is fully complementary to the target sequence
- the molecular beacon probe is complementary to the target sequence or hybridizable to the target sequence, and the molecular beacon probe does not overlap with the binding regions of the amplification primers P1 and P2 on the target sequence;
- the single-stranded target when the single-stranded target is single-stranded DNA, the single-stranded target can be single-stranded DNA and the double-stranded DNA is contacted with the double-stranded DNA through a nickase and a DNA polymerase, and a nick is generated under the action of the nickase, and the DNA polymerizes
- the enzyme amplifies and displaces the resulting single-stranded product from the nick;
- the DNA polymerase has a strand displacement function
- the methods are for non-disease diagnosis purposes.
- the positions of the base regions complementary to the target sequence on the amplification primers P1 and P2 are modified, and the modification methods include locked nucleic acid modification and methylation modification;
- the distance between the 3' terminal bases of the amplification primers P1 and P2 on the target sequence is not less than 10 bp.
- Molecular beacons may contain conventional synthetic modifications similar to the primers described above.
- the length of the molecular beacon is 13-80bp, and the binding position of the molecular beacon to the target sequence is not less than 12bp near the 5' end and 3'.
- the length of the amplification primer is between 17-40bp
- the replacement primer is between 10-30bp
- the GC% content is between 20-80%
- the probe length is between 20-40bp
- the GC% content is 10% Between -80%.
- the method for isothermally amplifying nucleic acid target sequences provided by the present invention is closed-tube real-time fluorescence detection. After the sample nucleic acid is loaded, the reaction is carried out on the machine, and there is no tube opening process in the middle, which avoids the possibility of product contamination caused by opening the cap.
- the single-stranded target is 30-100 bases in length;
- the amplification is implemented between 37°C-70°C;
- the entire reaction time is 1-10 minutes.
- the reaction time of the method is no more than 8 minutes. Positive and negative results can be obtained within 8 minutes. When there is a high concentration of positive target sequences in the sample, a positive result can be obtained within 1-2 minutes.
- the nickase is selected from Nt.AlwI, Nb.BbvCI, Nt.BbvCI, Nb.BsrDI, Nb.BsmI, Nt.BsmAI, Nt.BspQI, Nt.BstNBI, Nb.BtsI, Nt.CviPII at least one.
- the DNA polymerase is selected from one of Bst DNA polymerase, Bsu DNA polymerase, phi29 DNA polymerase.
- the DNA polymerase is Bst 2.0 or Bst3.0.
- one end of the molecular beacon probe is a fluorescent group
- the other end is a fluorescent quenching group
- the 5' end and 3' end of the probe are partially complementary in sequence, forming a stem-loop structure.
- the amplification reaction system includes Tris HCl buffer, BSA, NaCl, KCl, dNTP, Mg2+, (NH4)2SO4 and additives.
- the additive includes at least one of trehalose, betaine, dimethyl sulfoxide, gelatin, Tween 20, Triton-x100, and NP-40.
- the present invention provides a kit for realizing the method, which at least includes the amplification primers P1 and P2, displacement primers, molecular beacon probes and amplification reaction system in the above-mentioned method.
- the method for isothermally amplifying a nucleic acid target sequence provided by the invention has the following beneficial effects:
- the novel method for rapid isothermal amplification and nucleic acid detection provided by the present invention.
- This method is applicable to double-stranded DNA, single-stranded DNA, and single-stranded RNA, including the joint reaction of nickase and strand displacement enzyme.
- three primers and one probe are used, while When performing single-stranded RNA detection, it can be 3 primers and 1 probe, or 2 primers and 1 probe.
- the probe is a molecular beacon, which does not degrade during the amplification process and is only used to specifically bind the target fragment to provide a fluorescent signal and ensure the specificity of the reaction.
- the entire reaction process of the present invention is carried out under isothermal conditions, and there is no need to denature the target sequence before amplification, which is easier to operate than variable temperature nucleic acid amplification detection technology.
- Both the upstream and downstream amplification primers of the present invention introduce the nucleic acid sequence of the nicking enzyme recognition site, and the 5' and 3' ends of the double-stranded initial product that can be obtained have a nicking enzyme cleavage recognition site, which can effectively improve
- the reaction efficiency of the subsequent exponential amplification stage can complete the reaction in a shorter time; and the present invention uses locked nucleic acid to modify the primer, so that the efficiency and stability of primer and template binding are better than conventional primers; at the same time, the reaction system increases the reaction efficiency
- the additives and the upgraded version of DNA polymerase with strand displacement activity further improve the reaction efficiency of the reaction system, making the reaction time shorter, and the reaction is completed within 8 minutes, while the general isothermal amplification reaction takes more than 30-60 minutes.
- the present invention is more in line with the POCT detection requirement.
- the present invention uses a beacon probe that does not overlap with the primer binding region on the target sequence to judge the result in real time.
- the beacon probe has strong specificity in binding to the target sequence, and avoids the use of dye method or electrochemical method False positives caused by other protocols; at the same time, the tube is not opened after the reaction to further avoid false positives caused by product contamination.
- Fig. 1 is a schematic diagram of detecting double-stranded DNA in a preferred embodiment of the present invention.
- Fig. 2 is a schematic diagram of initial template formation when detecting single-stranded DNA and single-stranded RNA in a preferred embodiment of the present invention.
- Fig. 3 is a schematic diagram of initial template formation when detecting single-stranded RNA in a preferred embodiment of the present invention.
- Fig. 4 is a diagram showing the amplification effect of a plasmid carrying human gene PSMB2 in a preferred embodiment of the present invention.
- Fig. 5 is a diagram showing the effect of amplification of samples for detecting Mycoplasma pneumoniae in a preferred embodiment of the present invention.
- Fig. 6 is a diagram showing the amplification effect of detecting influenza B samples in a preferred embodiment of the present invention.
- Fig. 7 is a diagram showing the amplification effect of detecting parvovirus in a preferred embodiment of the present invention.
- Fig. 8 is a schematic diagram of the strand displacement amplification of the sample itself in a preferred embodiment of the present invention.
- Fig. 9 is a graph showing the amplification effect of the sample self-strand displacement amplification reaction in a preferred embodiment of the present invention.
- the invention provided by the invention provides a new method for rapid isothermal amplification and detection of double-stranded DNA, single-stranded DNA and single-stranded RNA. Including the following steps:
- the reaction includes an initial product generation stage (double-stranded initial product formation stage) and an exponential amplification signal acquisition stage.
- the nickase acts on the nickase cut site on the double-stranded DNA template to form a nick
- the strand displacement enzyme DNA polymerase with strand displacement function
- the primer with a single-strand enzyme cleavage site F/R, that is, the amplification primer P1
- the displacement primer B
- an enzyme-containing The single-stranded product of the cleavage site, another primer (R/F, amplification primer P2) with a single-stranded restriction site binds to and extends the single-stranded product, and then undergoes restriction digestion and strand displacement to form an initial
- the product is a double-stranded initial product with two restriction sites at both ends ( Figure 1).
- the primer (F/R) and the displacement primer (B) with a single-stranded restriction site bind to the single-stranded product, and the initial product is formed through the same process as above ( Figure 2) .
- the template is single-stranded RNA
- the primer (B) when using a reverse transcriptase with RNase H activity, the primer (B) does not need to be replaced, as shown in Figure 3, through reverse transcription and RNase H, a single strand with an enzyme cleavage site is formed, and the subsequent The reaction is the same as above; the second one uses reverse transcriptase (such as Bst 3.0) to generate a single strand with a restriction site through reverse transcription and strand displacement, and the process is similar to a single-stranded DNA template.
- reverse transcriptase such as Bst 3.0
- the nicking enzyme creates nicks on the initial product to form two double-stranded DNAs with enzyme cleavage sites on one side, as shown in the "exponential amplification" area of Figure 4, the first product Under the action of nickase and amplification enzyme, a single-stranded product can be generated, and the product can be further combined with the amplification primer and extended to form the second product; conversely, the second product can also generate the first product, and the two form exponential expansion.
- Molecular beacon probes can be combined with one of the single-stranded products, and a suitable fluorescent detection system can collect the amplification signal.
- This method uses 2 amplification primers, 1 displacement primer and 1 molecular beacon probe when detecting double-stranded DNA, single-stranded DNA and single-stranded RNA; it can also be 2 amplification primers when detecting single-stranded RNA Primers and 1 molecular beacon probe.
- the length of the molecular beacon is 13-80bp, and the binding position of the molecular beacon and the target sequence is not less than 12bp near the 5' end and 3'.
- the amplification enzyme used in the present invention has the function of synthesizing DNA with DNA as a template, and at the same time has the function of strand displacement, and some types of amplification enzymes also have the function of reverse transcription into DNA with RNA as a template.
- the length of the specific region of the initial product (not counting sequences such as restriction sites introduced by primer amplification) is between 30-100 bp.
- the molecular signal probe When the molecular signal probe binds to the single-stranded product, it does not overlap with the binding region of the amplification primer on the single-stranded product.
- the distance between the 3' terminal bases of the amplification primers P1 and P2 on the target sequence is not less than 10 bp.
- the temperature is constant during the reaction, and the reaction can be completed within 8 minutes.
- the present invention uses 3 primers and 1 beacon probe (when detecting single-stranded RNA, it can be 2 primers and 1 probe), nickase and strand displacement DNA polymerase, and can complete nucleic acid amplification within 8 minutes and real-time fluorescence detection of the product.
- the method is isothermal amplification, the temperature in the reaction is constant, and the reaction temperature is between 37-70°C.
- the reaction time of the method does not exceed 8 minutes, positive and negative results are obtained within 8 minutes, and positive results can be obtained within 1-2 minutes when there is a high concentration of positive target sequences in the sample.
- the method is closed-tube real-time fluorescence detection. After adding the sample nucleic acid, the reaction is carried out on the machine, and there is no process of opening the tube in the middle.
- the primer is a single-stranded nucleotide polymer, and if necessary, the primer may contain conventional synthetic modifications such as locked nucleic acid (LNA) and methylation.
- LNA locked nucleic acid
- 1 is a strand displacement primer
- 2 are amplification primers.
- the strand displacement primer is completely complementary to the template, and the amplification primer contains 3 regions, which are the specific binding region, the enzyme cleavage site region and the stable region. .
- the beacon probe refers to a single-stranded nucleotide polymer modified with a fluorescent group and a quencher group, and artificial sequences at the 5' and 3' ends are complementary to form a stem-loop structure. If necessary, routine synthetic modifications similar to those described above for the primers may be included, as well as spacer modifications at the 5' and 3' ends to increase their length. Beacon probes and primers have no overlapping parts on the target sequence, ensuring their specificity.
- the nickase is a kind of special enzyme that recognizes the specific sequence of double-stranded DNA and forms a nick thereon, such as Nt.AlwI, Nb.BbvCI, Nt.BbvCI, Nb.BsrDI, Nb.BsmI, Nt.BsmAI, Nt. BspQI, Nt.BstNBI, Nb.BtsI, Nt.CviPII or other enzymes having the same function.
- the strand-displacing DNA polymerase is a kind of polymerase that has the activity of polymerizing at the 3' terminal of nucleic acid and also has the function of displacing nucleic acid in the direction of polymerization.
- Bst DNA polymerase including Bst 2.0, Bst3.0 and other upgraded products
- Bst DNA polymerase large fragment Bsu DNA polymerase
- Bsu DNA polymerase large fragment phi29 DNA polymerase, etc.
- the method also includes various substances used in common nucleic acid amplification reactions, such as Tris HCl buffer, BSA, NaCl, KCl, dNTP, Mg2+, (NH4)2SO4 and other reactions Commonly used buffers and ionic components, as well as additives such as trehalose, betaine, dimethyl sulfoxide, gelatin, Tween 20, Triton-x100, NP-40, etc.
- Example 1 The detection comparison of the plasmid carrying the human gene PSMB2
- Experimental group using upgraded DNA polymerase, primers to introduce locked nucleic acid markers, reaction system adding reaction enhancer and control group: using low-level version of DNA polymerase, primers not locked nucleic acid markers, reaction system without adding reaction Enhancers were compared for reaction times.
- composition of the amplification reaction system of the present invention and the control group, additives and the modified situation of the primers used are as follows in Table 1:
- the primer probe sequence (5'-3') is as follows:
- PSMB2-B (primer): CCCAGCACTTT
- PSMB2-F (primer): TTCAGACTATTGAGTCTATTCTGACCA A CAT
- PSMB2-R (primer): GTCAGACTATTGAGTCTTCTCCCAGCT A AT
- PSMB2-P (probe): ATGGTAGTAGAGACGGGGTTTTTACCAT
- the primer probe sequence (5'-3') is as follows:
- PSMB2-B (primer): CCCAGCACTTT
- PSMB2-F (primer): TTCAGACTATTGAGTCTATTCTGACCAACAT
- PSMB2-R (primer): GTCAGACTATTGAGTCTTCTCCCAGCTAAT
- PSMB2-P (probe): ATGGTAGTAGAGACGGGGTTTTTACCAT
- Control group 1 Control group 2
- Control group 3 Control group 4 detection time 2.5-4min 5-9min 5.5-9min 7-10min 9-12min
- the detection time of the present invention is significantly earlier than that of the control groups, indicating that the present invention has a better time advantage in the application of double-stranded DNA nucleic acid detection.
- Experimental group using upgraded DNA polymerase, primers for nucleic acid-locking labeling, reaction system adding reaction enhancer and control group: using low-level version of DNA polymerase, primers for nucleic acid-locking labeling, no reaction added to the reaction system Enhancers were compared for reaction times.
- composition of the amplification reaction system of the present invention and the control group, the additives and the modified conditions of the primers used are as follows in Table 3:
- the primer probe sequence (5'-3') is as follows:
- Mp-P (probe): CGCAGCTGGTTACGGGAATACTGCG
- the primer probe sequence (5'-3') is as follows:
- Mp-P (probe): CGCAGCTGGTTACGGGAATACTGCG
- the instrument was LightCycler480II. Detected 8 lung branch samples, and 8 other respiratory pathogens: influenza A virus, influenza B virus, Chlamydia pneumoniae, respiratory syncytial virus, human parvovirus B19, Staphylococcus aureus, human respiratory adenovirus, rhinovirus, The results of each group are shown in Table 4, and the graph of the detection results of the present invention is shown in Figure 5. The following table shows the comparison results of the detection of Mycoplasma pneumoniae.
- Control group 1 Control group 2
- Control group 3 Control group 4 detection time 3-7min 10-15min 14-19min 15-19min 18-22min Detection of non-specific 0/8 2/8 0/8 1/8 2/8
- the present invention has obvious advantages in the detection time and detection specificity of double-stranded DNA nucleic acid.
- Example 3 Influenza B virus (single-stranded RNA virus) clinical sample detection comparison
- Experimental group using upgraded DNA polymerase, primers to introduce locked nucleic acid markers, adding reaction enhancer to the reaction system and control group: using a low-level version of DNA polymerase, primers for locked nucleic acid markers, no reaction added to the reaction system Enhancers were compared for reaction times.
- composition of the amplification reaction system of the present invention and the control group, the additives and the modification of the primers used are as follows in Table 5:
- the primer probe sequence (5'-3') is as follows:
- the primer probe sequence (5'-3') is as follows:
- the instrument was LightCycler 480II. Detected 8 clinical samples of influenza B virus, and 8 other respiratory pathogens: influenza A virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, respiratory syncytial virus, human parvovirus B19, Staphylococcus aureus, human respiratory adenovirus, rhinovirus To verify the specificity of the reaction system, the results of each group are shown in Table 3, and the graph of the detection results of the present invention is shown in Figure 6.
- Table 6 is the detection and comparison results of influenza B virus.
- Control group 1 Control group 2
- Control group 3 Control group 4 detection time 3-5min 7-10min 9-13min 11-15min 20-24min Detection of non-specific 0/8 1/8 0/8 1/8 2/8
- Experimental group using upgraded DNA polymerase, primers to introduce locked nucleic acid markers, adding reaction enhancer to the reaction system and control group: using a low-level version of DNA polymerase, primers for locked nucleic acid markers, no reaction added to the reaction system Enhancers were compared for reaction times.
- composition of the amplification reaction system of the present invention and the control group, the additives and the modified conditions of the primers used are as follows in Table 7:
- CVP-F (primer): GAACTTTTGAGTCTTTTACTATAC A CATC
- CVP-R (primer): GAACTTTTGAGTCTTTTTCCCAGTTTTC A T
- CVP-P (probe): CGCCAGGAAAAGTACCAGAATGGCG
- CVP-F (primer): GAACTTTTGAGTCTTTTACTATAC A CATC
- CVP-R (primer): GAACTTTTGAGTCTTTTTCCCAGTTTTC A T
- CVP-P (probe): CGCCAGGAAAAGTACCAGAATGGCG
- the present invention has obvious advantages in detection time and detection specificity of single-stranded DNA nucleic acid.
- the following table 8 is the detection and comparison results of canine parvovirus.
- Control group 1 Control group 2
- Control group 3 Control group 4 detection time 3.5-5min 8-12min 9-15min 13-17min 15-22min Detection of non-specific 0/8 2/8 0/8 2/8 3/8
- the reaction was carried out at 55°C, and the signal was collected every 1 min for a total of 60 cycles.
- the instrument was LightCycler 480II.
- the samples were nucleic acid stock solution extracted from throat swabs, 10 times and 100 dilutions of the stock solution, and each was repeated twice.
- the results are shown in Figure 9, the nucleic acid sample extracted from the throat swab showed an amplification signal in about 12 minutes.
- strand displacement enzyme and nickase are used for amplification, self-amplification of the sample is inevitable.
- CN104726549A uses the dye method to judge the result, when the reaction is carried out for 30-60 minutes, the occurrence of this false positive phenomenon cannot be avoided.
Abstract
Description
组别group | 本发明this invention | 对照组1Control group 1 | 对照组2Control group 2 | 对照组3Control group 3 | 对照组4Control group 4 |
检测时间detection time | 2.5-4min2.5-4min | 5-9min5-9min | 5.5-9min5.5-9min | 7-10min7-10min | 9-12min9-12min |
组别group | 本发明this invention | 对照组1Control group 1 | 对照组2Control group 2 | 对照组3Control group 3 | 对照组4Control group 4 |
检测时间detection time | 3-7min3-7min | 10-15min10-15min | 14-19min14-19min | 15-19min15-19min | 18-22min18-22min |
检测非特异性Detection of non-specific | 0/80/8 | 2/82/8 | 0/80/8 | 1/81/8 | 2/82/8 |
组别group | 本发明this invention | 对照组1Control group 1 | 对照组2Control group 2 | 对照组3Control group 3 | 对照组4Control group 4 |
检测时间detection time | 3-5min3-5min | 7-10min7-10min | 9-13min9-13min | 11-15min11-15min | 20-24min20-24min |
检测非特异性Detection of non-specific | 0/80/8 | 1/81/8 | 0/80/8 | 1/81/8 | 2/82/8 |
组别group | 本发明this invention | 对照组1Control group 1 | 对照组2Control group 2 | 对照组3Control group 3 | 对照组4Control group 4 |
检测时间detection time | 3.5-5min3.5-5min | 8-12min8-12min | 9-15min9-15min | 13-17min13-17min | 15-22min15-22min |
检测非特异性Detection of non-specific | 0/80/8 | 2/82/8 | 0/80/8 | 2/82/8 | 3/83/8 |
Claims (11)
- 等温扩增核酸靶序列的方法,其特征在于,包括如下步骤:A method for isothermally amplifying a nucleic acid target sequence, comprising the steps of:I、初始产物形成包括如下步骤:1, initial product formation comprises the following steps:A1、当所述单链靶标为单链的DNA时,将扩增引物P1和置换引物与单链靶标互补结合,在DNA聚合酶的作用下沿所述单链靶标延伸扩增引物P1的同时用置换引物置换扩增引物P1的扩增产物;将由被置换出来的扩增引物P1延伸形成的产物作为单链模板;A1. When the single-stranded target is single-stranded DNA, the amplification primer P1 and the displacement primer are complementary combined with the single-stranded target, and the amplification primer P1 is extended along the single-stranded target under the action of DNA polymerase replacing the amplification product of the amplification primer P1 with the replacement primer; using the product formed by the extension of the replaced amplification primer P1 as a single-stranded template;A2、当所述单链靶标为单链RNA时,可通过两种方式反应获得单链模板:A2. When the single-stranded target is a single-stranded RNA, the single-stranded template can be obtained by reacting in two ways:(1)若所述DNA聚合酶兼具聚合酶功能、链置换功能和反转录功能,将扩增引物P1、置换引物和DNA聚合酶与单链RNA接触,所述单链RNA在DNA聚合酶反转录活性作用下反转录成cDNA,并被置换引物置换得到单链模板;(1) If the DNA polymerase has both polymerase function, strand displacement function and reverse transcription function, the amplification primer P1, displacement primer and DNA polymerase are contacted with single-stranded RNA, and the single-stranded RNA is Reverse transcribe into cDNA under the action of enzymatic reverse transcription activity, and be replaced by a displacement primer to obtain a single-stranded template;(2)若所述DNA聚合酶不具备反转录功能,需添加兼具RNase H活性的反转录酶,将扩增引物P1和反转录酶与单链RNA接触,所述单链RNA在反转录酶作用下反转录成cDNA,形成cDNA-RNA复合双链产物,复合双链产物中的RNA链在反转录酶的RNase H活性作用下水解得到单链模板;(2) If the DNA polymerase does not have the reverse transcription function, it is necessary to add a reverse transcriptase with RNase H activity, and contact the amplification primer P1 and the reverse transcriptase with the single-stranded RNA, and the single-stranded RNA Under the action of reverse transcriptase, it is reverse transcribed into cDNA to form a cDNA-RNA composite double-stranded product, and the RNA strand in the composite double-stranded product is hydrolyzed by the RNase H activity of reverse transcriptase to obtain a single-stranded template;B、将扩增引物P2与步骤A形成的单链模板互补结合,在DNA聚合酶的作用下沿所述单链模板延伸扩增引物P2,再由切口酶作用于延伸产物,在切口处延伸并置换,形成两端各具1个酶切位点的双链初始产物;B. The amplification primer P2 is complementary to the single-stranded template formed in step A, and the amplification primer P2 is extended along the single-stranded template under the action of DNA polymerase, and then the nicking enzyme acts on the extension product to extend at the nick and replacement to form a double-stranded initial product with one enzyme cleavage site at each end;II、指数扩增信号采集包括以下步骤:II, the exponential amplification signal collection comprises the following steps:C、将切口酶和DNA聚合酶与双链模板接触,所述双链模板在切口酶作用下产生双链切口位点,DNA聚合酶从所述切口位点出发扩增并置换得到可与扩增引物P1或P2互补的单链;C. Contacting a nicking enzyme and a DNA polymerase with a double-stranded template, the double-stranded template generates a double-stranded nicking site under the action of the nicking enzyme, and the DNA polymerase amplifies and displaces from the nicking site to obtain a Increase the single strand complementary to primer P1 or P2;D、将扩增引物P1或P2与步骤C形成的单链互补结合,并在DNA聚合酶的作用下延伸形成两种各具1个酶切位点的双链产物;D. Complementary binding of amplification primer P1 or P2 to the single strand formed in step C, and extension under the action of DNA polymerase to form two double strand products each with one restriction site;E、将切口酶和DNA聚合酶与步骤D产生的两种双链产物接触,所述两种双链产物在切口酶作用下分别形成切口,DNA聚合酶从所述切口位点出发扩增并置换,分别得到可与扩增引物P1或P2互补的两条单链;单链再与扩增引物P1或P2接触,并在DNA聚合酶的作用下延伸形成双链产物;E. Contacting the nicking enzyme and the DNA polymerase with the two double-stranded products produced in step D, the two double-stranded products form nicks respectively under the action of the nicking enzyme, and the DNA polymerase amplifies from the nicking site and Replacement to obtain two single strands that can be complementary to the amplification primer P1 or P2 respectively; the single strand is then contacted with the amplification primer P1 or P2, and extended under the action of DNA polymerase to form a double-stranded product;F、重复步骤E,以指数形式得到扩增产物;F. Repeat step E to obtain the amplification product exponentially;其中,上述步骤在等温的条件下实施,且无需在扩增前对靶序列进行变性;Wherein, the above steps are carried out under isothermal conditions, and there is no need to denature the target sequence before amplification;步骤C~F还包括将扩增体系与分子信标探针互补结合,以提供荧光信号;Steps C to F also include complementary binding of the amplification system to molecular beacon probes to provide fluorescent signals;所述扩增引物P1和P2,沿5′-3′方向,依次包含稳定区、切口酶识别位点区以及能与靶序列互补的碱基区域;其中所述稳定区的长度为6-20bp;The amplification primers P1 and P2, along the 5'-3' direction, sequentially include a stable region, a nickase recognition site region and a base region complementary to the target sequence; wherein the length of the stable region is 6-20bp ;所述置换引物与靶序列完全互补;The displacement primer is fully complementary to the target sequence;所述分子信标探针与靶序列互补或可与靶序列杂交,所述分子信标探针与所述扩增引物P1、P2在靶序列上的结合区域没有重叠;The molecular beacon probe is complementary to the target sequence or hybridizable to the target sequence, and the molecular beacon probe does not overlap with the binding regions of the amplification primers P1 and P2 on the target sequence;所述单链靶标为单链的DNA时,所述单链靶标可以为单链DNA以及由双链DNA经切口酶和DNA聚合酶与双链DNA接触,在切口酶作用下产生切口,DNA聚合酶从所述切口出发扩增并置换得到的单链产物;When the single-stranded target is single-stranded DNA, the single-stranded target can be single-stranded DNA and the double-stranded DNA is contacted with the double-stranded DNA through a nickase and a DNA polymerase, and a nick is generated under the action of the nickase, and the DNA polymerizes The enzyme amplifies and displaces the resulting single-stranded product from the nick;所述DNA聚合酶具有链置换功能;The DNA polymerase has a strand displacement function;所述方法为非疾病诊断目的。The methods are for non-disease diagnostic purposes.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:The method for isothermally amplifying a nucleic acid target sequence according to claim 1, characterized in that:所述扩增引物P1、P2上与靶序列互补的碱基区域位置进行修饰,所述修饰方式包括锁核酸修饰、甲基化修饰;The position of the base region complementary to the target sequence on the amplification primers P1 and P2 is modified, and the modification method includes locked nucleic acid modification and methylation modification;所述扩增引物P1和P2的3′端末端碱基之间处在靶序列上的距离不小于10bp。The distance between the 3' terminal bases of the amplification primers P1 and P2 on the target sequence is not less than 10 bp.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述分子信标的长度为13-80bp,且所述分子信标与所述靶序列的结合位置为临近5‘端和3’不小于12bp的位置处。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, characterized in that: the length of the molecular beacon is 13-80bp, and the binding position of the molecular beacon and the target sequence is close to the 5' end and 3' not less than 12bp position.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:The method for isothermally amplifying a nucleic acid target sequence according to claim 1, characterized in that:所述单链靶标的长度为30-100个碱基;The length of the single-stranded target is 30-100 bases;所述扩增是在37℃-70℃之间实施;The amplification is implemented between 37°C-70°C;整个反应时间为1-10min。The whole reaction time is 1-10min.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述切口酶选自Nt.AlwI、Nb.BbvCI、Nt.BbvCI、Nb.BsrDI、Nb.BsmI、Nt.BsmAI、Nt.BspQI、Nt.BstNBI、Nb.BtsI、Nt.CviPII中的至少一种。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein said nickase is selected from Nt.AlwI, Nb.BbvCI, Nt.BbvCI, Nb.BsrDI, Nb.BsmI, Nt.BsmAI, At least one of Nt.BspQI, Nt.BstNBI, Nb.BtsI, Nt.CviPII.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述DNA聚合酶选自Bst DNA聚合酶、Bsu DNA聚合酶、phi29 DNA聚合酶中的一种。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein said DNA polymerase is selected from one of Bst DNA polymerase, Bsu DNA polymerase, and phi29 DNA polymerase.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述DNA聚合酶为Bst 2.0或Bst3.0。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein said DNA polymerase is Bst 2.0 or Bst 3.0.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述分子信标探针的一端为荧光基团,另一端为荧光淬灭基团,且探针的5′端和3′端部分序列互补,可形成茎环结构。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein one end of the molecular beacon probe is a fluorescent group, the other end is a fluorescent quenching group, and the 5' end of the probe is Complementary to the partial sequence at the 3' end, a stem-loop structure can be formed.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述扩增反应体系中包括Tris HCl缓冲液、BSA、NaCl、KCl、dNTP、Mg2+、(NH4)2SO4以及添加剂。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein the amplification reaction system includes Tris HCl buffer, BSA, NaCl, KCl, dNTP, Mg2+, (NH4)SO4 and additives.
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述添加剂包括海藻糖、甜菜碱、二甲基亚砜、明胶、吐温20、Triton-x100、NP-40中的至少一种。The method for isothermally amplifying nucleic acid target sequences according to claim 1, wherein said additives include trehalose, betaine, dimethyl sulfoxide, gelatin, Tween 20, Triton-x100, NP-40 at least one of .
- 根据权利要求1所述的等温扩增核酸靶序列的方法,其特征在于:所述试剂盒包括权利要求1-10任一项所述方法中所述的扩增引物P1、P2、置换引物、分子信标探针以及扩增反应体系。The method for isothermally amplifying a nucleic acid target sequence according to claim 1, wherein the kit includes the amplification primers P1, P2, replacement primers, Molecular beacon probe and amplification reaction system.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112023027256A BR112023027256A2 (en) | 2021-06-30 | 2022-06-29 | METHOD FOR ISOTHERMICALLY AMPLIFYING A TARGET SEQUENCE OF NUCLEIC ACIDS |
AU2022301095A AU2022301095A1 (en) | 2021-06-30 | 2022-06-29 | Method for isothermal amplification of nucleic acid target sequences |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110733555.7A CN113481283A (en) | 2021-06-30 | 2021-06-30 | Method for isothermal amplification of nucleic acid target sequences |
CN202110733555.7 | 2021-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023274330A1 true WO2023274330A1 (en) | 2023-01-05 |
Family
ID=77937009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/102545 WO2023274330A1 (en) | 2021-06-30 | 2022-06-29 | Method for isothermal amplification of nucleic acid target sequences |
Country Status (4)
Country | Link |
---|---|
CN (2) | CN113481283A (en) |
AU (1) | AU2022301095A1 (en) |
BR (1) | BR112023027256A2 (en) |
WO (1) | WO2023274330A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113481283A (en) * | 2021-06-30 | 2021-10-08 | 上海伯杰医疗科技有限公司北京分公司 | Method for isothermal amplification of nucleic acid target sequences |
CN113981047B (en) * | 2021-11-08 | 2023-11-07 | 中国科学院合肥物质科学研究院 | Reverse transcription-strand displacement amplification method for miRNA detection and application thereof |
CN114350756A (en) * | 2021-11-22 | 2022-04-15 | 西安交通大学 | Whole genome self-priming amplification method and kit based on DNA nicking/polymeric strand displacement cycle reaction |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104726549A (en) * | 2014-10-10 | 2015-06-24 | 青岛科技大学 | Novel method for isothermal amplification detection of double-stranded nucleic acid based on nicking enzyme |
US20180127815A1 (en) * | 2013-03-11 | 2018-05-10 | Elitechgroup B.V. | Methods for true isothermal strand displacement amplification |
CN108642144A (en) * | 2018-05-18 | 2018-10-12 | 贠红岩 | A kind of constant temperature strand displacement amplification and kit |
CN113481283A (en) * | 2021-06-30 | 2021-10-08 | 上海伯杰医疗科技有限公司北京分公司 | Method for isothermal amplification of nucleic acid target sequences |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111850100B (en) * | 2020-07-21 | 2022-12-13 | 北京艾克伦医疗科技有限公司 | Nucleic acid amplification method and application thereof |
-
2021
- 2021-06-30 CN CN202110733555.7A patent/CN113481283A/en active Pending
-
2022
- 2022-06-29 CN CN202210751117.8A patent/CN115074419A/en active Pending
- 2022-06-29 AU AU2022301095A patent/AU2022301095A1/en active Pending
- 2022-06-29 WO PCT/CN2022/102545 patent/WO2023274330A1/en active Application Filing
- 2022-06-29 BR BR112023027256A patent/BR112023027256A2/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180127815A1 (en) * | 2013-03-11 | 2018-05-10 | Elitechgroup B.V. | Methods for true isothermal strand displacement amplification |
CN104726549A (en) * | 2014-10-10 | 2015-06-24 | 青岛科技大学 | Novel method for isothermal amplification detection of double-stranded nucleic acid based on nicking enzyme |
CN108642144A (en) * | 2018-05-18 | 2018-10-12 | 贠红岩 | A kind of constant temperature strand displacement amplification and kit |
CN113481283A (en) * | 2021-06-30 | 2021-10-08 | 上海伯杰医疗科技有限公司北京分公司 | Method for isothermal amplification of nucleic acid target sequences |
Non-Patent Citations (1)
Title |
---|
ZHOU MEILING: "Study on New Technologies of Isothermal Nucleic Acid Amplification Based on Nicking Enzyme", ENGINEERING SCIENCE & TECHNOLOGY I, CHINA MASTER’S THESES FULL-TEXT DATABASE, no. 8, 15 August 2016 (2016-08-15), XP093018187 * |
Also Published As
Publication number | Publication date |
---|---|
CN113481283A (en) | 2021-10-08 |
AU2022301095A1 (en) | 2024-01-18 |
BR112023027256A2 (en) | 2024-03-12 |
CN115074419A (en) | 2022-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023274330A1 (en) | Method for isothermal amplification of nucleic acid target sequences | |
US10851406B2 (en) | Nicking and extension amplification reaction for the exponential amplification of nucleic acids | |
Zhong et al. | Isothermal amplification technologies for the detection of foodborne pathogens | |
JP6542771B2 (en) | Nucleic acid probe and genomic fragment detection method | |
US9617587B1 (en) | Isothermal amplification components and processes | |
US11802282B2 (en) | Method for identifying gene fusions by circle cDNA amplification | |
CN113308519B (en) | Primer and probe for detecting single base mutation site and detection method | |
AU2006226873B2 (en) | Nucleic acid detection | |
CN112280832B (en) | Extraction-free nucleic acid detection method and kit | |
CN110684826B (en) | Recombinase-based loop-mediated amplification method | |
CN114292958A (en) | Respiratory tract pathogen multi-connection detection kit and application thereof | |
Li et al. | One-pot, ultrasensitive, and multiplex detection of SARS-CoV-2 genes utilizing self-priming hairpin-mediated isothermal amplification | |
US20090305288A1 (en) | Methods for amplifying nucleic acids and for analyzing nucleic acids therewith | |
US20220380755A1 (en) | De-novo k-mer associations between molecular states | |
WO2023201487A1 (en) | Adapter, adapter ligation reagent, kit, and library construction method | |
WO2022222937A1 (en) | Primer group and method for detecting single-base mutations | |
TawheedShafi et al. | Molecular Diagnosis of Infectious Diseases | |
WO2023092178A1 (en) | Improved isothermal amplification | |
Xu et al. | A split single-stranded DNA activator-based Cas12a fluorescence biosensor for specific H1N1 detection | |
Debnath et al. | Polymerase chain reaction | |
WO2023215524A2 (en) | Primary template-directed amplification and methods thereof | |
CN115287337A (en) | Denatured nested phosphorothioate isothermal nucleic acid amplification method | |
Lefferts et al. | Essential Concepts and Techniques in Molecular Biology | |
CN115851886A (en) | LAMP amplification-based fluorescence detection and CRISPR/Cas detection dual detection system and application | |
CN114134254A (en) | Molecular logic gate intelligent detection system for detecting coronavirus and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22832142 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022301095 Country of ref document: AU Ref document number: AU2022301095 Country of ref document: AU |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112023027256 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2022301095 Country of ref document: AU Date of ref document: 20220629 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 112023027256 Country of ref document: BR Kind code of ref document: A2 Effective date: 20231222 |